Description

This standardized extract from the Chinese club moss is an all-natural herbal supplement that has been shown to maintain healthy levels of acetylcholine.^608-614 This product is standardized for maximum efficacy. This moss has been used in traditional Chinese medicine for promoting optimal memory function.^605-620

In a double-blind, matched pair trial of 34 pairs of middle school students, results showed an increase of nearly 11% of the memory quotient. It concluded Huperizine A may enhance memory and learning performance.¹ Other studies indicate significant improvement in memory for those with Alzheimer’s disease and patients with vascular dementia.^2,3

 

Supplement Facts

Serving Size: 1 vegetarian capsule Servings Per Container: 60
Amount Per Serving
Huperzine A [from (Huperzia serrata) extract (whole herb)]	200 mcg
Other Ingredients: microcrystalline cellulose, vegetable cellulose (capsule), maltodextrin, vegetable stearate, silica.

Dosage and Use:

• Take one to two capsules once or twice daily with or without food, or as recommended by a healthcare practitioner.

Caution: If you suffer from abnormal or irregular heart rhythm (e.g. atrial fibrillation) and congestive heart failure, avoid Huperzine A. Consult your healthcare provider before taking this product if you are being prescribed an acetylcholinesterase inhibitor. Huperzine A can cause gastrointestinal discomfort for some individuals.

Warnings:

• If pregnant, nursing, or undergoing treatment for a medical condition, consult your physician before taking this product
• Keep out of reach of children
• Do not exceed recommended dose

References:

1. Huperzine-A capsules enhance memory and learning performance in 34 pairs of matched adolescent students.
2. Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer’s disease.
3. Treatment with Huperzine A improves cognition in vascular dementia patients.
605. J Pharmacol Exp Ther. 1998 Sep;286(3):1122-8.
606. Phytother Res. 2002 Jun;16(4):368-72.
607. Int J Food Sci Nutr. 2013 Feb;64(1):7-15.
608. Trends Pharmacol Sci. 2006 Dec;27(12):619-25.
609. Neurosci Lett. 2004 May 6;361(1-3):56-9.
610. Eur J Pharmacol. 2002 Nov 29;455(2-3):101-7.
611. Zhongguo Yao Li Xue Bao. 1999 Feb;20(2):141-5.
612. Cell Mol Neurobiol. 2008 Feb;28(2):173-83.
613. Curr Alzheimer Res. 2007 Sep;4(4):386-96.
614. Acta Pharmacol Sin. 2006 Sep;27(9):1127-36.
615. Chem Biol Interact. 2008 Sep 25;175(1-3):396-402.
616. Pharmacol Biochem Behav. 2006 Apr;83(4):603-11.
617. Zhonghua Yi Xue Za Zhi. 2002 Jul 25;82(14):941-4.
618. Zhongguo Yao Li Xue Bao. 1999 Jul;20(7):601-3.
619. Zhongguo Yao Li Xue Bao. 1999 Jun;20(6):486-90.
620. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005592. doi: 10.1002/14651858.CD005592.pub2.

 

* These statements have not been evaluated by the Food and Drug Administration. This Product is not intended to diagnose, treat, cure or prevent any disease.